BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26177481)

  • 1. Longitudinal tracking of triple labeled umbilical cord derived mesenchymal stromal cells in a mouse model of Amyotrophic Lateral Sclerosis.
    Violatto MB; Santangelo C; Capelli C; Frapolli R; Ferrari R; Sitia L; Tortarolo M; Talamini L; Previdi S; Moscatelli D; Salmona M; Introna M; Bendotti C; Bigini P
    Stem Cell Res; 2015 Jul; 15(1):243-53. PubMed ID: 26177481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.
    Sironi F; Vallarola A; Violatto MB; Talamini L; Freschi M; De Gioia R; Capelli C; Agostini A; Moscatelli D; Tortarolo M; Bigini P; Introna M; Bendotti C
    Stem Cell Res; 2017 Dec; 25():166-178. PubMed ID: 29154076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells.
    Hu SL; Lu PG; Zhang LJ; Li F; Chen Z; Wu N; Meng H; Lin JK; Feng H
    J Cell Biochem; 2012 Mar; 113(3):1005-12. PubMed ID: 22065605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous injection of umbilical cord-derived mesenchymal stromal cells attenuates reactive gliosis and hypomyelination in a neonatal intraventricular hemorrhage model.
    Mukai T; Mori Y; Shimazu T; Takahashi A; Tsunoda H; Yamaguchi S; Kiryu S; Tojo A; Nagamura-Inoue T
    Neuroscience; 2017 Jul; 355():175-187. PubMed ID: 28504197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI tracking of transplanted iron-labeled mesenchymal stromal cells in an immune-compromised mouse model of critical limb ischemia.
    Noad J; Gonzalez-Lara LE; Broughton HC; McFadden C; Chen Y; Hess DA; Foster PJ
    NMR Biomed; 2013 Apr; 26(4):458-67. PubMed ID: 23165968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHBVHHx scaffolds loaded with umbilical cord-derived mesenchymal stem cells or hepatocyte-like cells differentiated from these cells for liver tissue engineering.
    Su Z; Li P; Wu B; Ma H; Wang Y; Liu G; Zeng H; Li Z; Wei X
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():374-82. PubMed ID: 25491842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human umbilical cord-derived mesenchymal stem cells in acute liver injury: Hepatoprotective efficacy, subchronic toxicity, tumorigenicity, and biodistribution.
    Yun JW; Ahn JH; Kwon E; Kim SH; Kim H; Jang JJ; Kim WH; Kim JH; Han SY; Kim JT; Kim JH; Kim W; Ku SY; Do BR; Kang BC
    Regul Toxicol Pharmacol; 2016 Nov; 81():437-447. PubMed ID: 27693706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization.
    Xu Y; Meng H; Li C; Hao M; Wang Y; Yu Z; Li Q; Han J; Zhai Q; Qiu L
    Stem Cells Dev; 2010 Oct; 19(10):1511-22. PubMed ID: 20170363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration.
    Bigini P; Veglianese P; Andriolo G; Cova L; Grignaschi G; Caron I; Daleno C; Barbera S; Ottolina A; Calzarossa C; Lazzari L; Mennini T; Bendotti C; Silani V
    Rejuvenation Res; 2011 Dec; 14(6):623-39. PubMed ID: 21978082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Tracking and Regenerative Capabilities of Transplanted Human Umbilical Cord-Derived Mesenchymal Stem Cells Labeled with I-III-IV Semiconducting Nanocrystals in Liver-Injured Living Mice.
    Chetty SS; Praneetha S; Govarthanan K; Verma RS; Vadivel Murugan A
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8763-8778. PubMed ID: 30741534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of chloromethyl-dialkylcarbocyanine and green fluorescent protein for labeling human umbilical mesenchymal stem cells.
    Ji F; Duan HG; Zheng CQ; Li J
    Biotechnol Lett; 2015 Feb; 37(2):437-47. PubMed ID: 25280731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles.
    Hu SL; Zhang JQ; Hu X; Hu R; Luo HS; Li F; Xia YZ; Li JT; Lin JK; Zhu G; Feng H
    J Cell Biochem; 2009 Oct; 108(2):529-35. PubMed ID: 19623584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking fusion of human mesenchymal stem cells after transplantation to the heart.
    Freeman BT; Kouris NA; Ogle BM
    Stem Cells Transl Med; 2015 Jun; 4(6):685-94. PubMed ID: 25848121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic properties of gadolinium diethylenetriaminepentaacetic acid-labeled and PKH26-labeled human umbilical cord mesenchymal stromal cells.
    Pan H; Lan J; Luo X; Gao J; Xie X; Guo H
    Cytotherapy; 2014 Jan; 16(1):74-83. PubMed ID: 23867163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model.
    Kim KS; Lee HJ; An J; Kim YB; Ra JC; Lim I; Kim SU
    Cell Transplant; 2014; 23(12):1585-97. PubMed ID: 24070071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis.
    Boido M; Piras A; Valsecchi V; Spigolon G; Mareschi K; Ferrero I; Vizzini A; Temi S; Mazzini L; Fagioli F; Vercelli A
    Cytotherapy; 2014 Aug; 16(8):1059-72. PubMed ID: 24794182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.